The U.S. Public Health Service has updated its clinical practice guidelines for the use of pre-exposure prophylaxis to prevent HIV infection, with new information on the safety and efficacy of PrEP from trials and open-label studies, indications for PrEP use, and a link to further information on the CDC website. Changes are highlighted in the updated guidelines.
This announcement is for a third-party program that The Forum for Collaborative Research does not control or provide support for. Please contact the organizers directly with any questions.